Vaccination strategy against Covid-19: role of the bivalent Spikevax Original / Omicron BA.4/BA.5 vaccine (mRNA-1273.222)

HAS recommends including the bivalent Spikevax Original/Omicron BA.4-5 15/15 µg vaccine in the booster vaccination strategy against Covid-19. In line with its previous recommendations, the HAS considers that this vaccine can be used in subjects over 30 years old who are eligible for the booster.